DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3+
SponsorPolish Cardiology Association
About this trial
The BNP-PL is a multicenter, observational study in which patients are prospectively followed in order to investigate clinical course and management of pulmonary hypertension in Poland.
All patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension confirmed in right heart catheterization, will be eligible to participate in the study.
Eligibility criteria
Qualifiers
are aged > 3 months at the time of enrollment
fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance (PVR) of 3 Woods.
are aged > 3 months at the time of enrollment
fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance (PVR) of 3 Woods
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
3,000 Participants
are grouped into 3 trial groupsSponsors and collaborators
Polish Cardiology Association
Lead sponsor
Jagiellonian University
Collaborator
Source ClinicalTrials.gov